A Visual Exploration of Antisense Oligonucleotide Therapies in Amyotrophic Lateral Sclerosis
0.50 hr(s) | CME
Specialty: Amyotrophic Lateral Sclerosis
Therapeutic Area(s): Neurology
Release Date: June 8, 2021
Expiration Date: June 7, 2022
Location: Internet Activity Enduring
In this activity, an expert in neurology discusses the use of antisense oligonucleotide therapies in patients with amyotrophic lateral sclerosis (ALS).